Table 5.
Concordance Between the Presence of Antibiotic Resistance (ABR) Genes and Antibiotic Susceptibility of Urine Samples from Symptomatic Patients with Urinary Tract Infection (UTI) by Antibiotic and Infection Status (Monomicrobial vs. Polymicrobial)
Antibiotics | Number of Associated ABR Genes Tested | Concordance Rate in All (N = 1155) | Concordance Rate in Monomicrobial Specimens (n = 886) | Concordance Rate in Polymicrobial Specimens (n = 269) | p value (Monomicrobial vs. Polymicrobial) |
---|---|---|---|---|---|
Amoxicillin /Clavulanate | 16 | 66.8% | 67.9% | 62.7% | 0.13 |
Ampicillin | 16 | 78.4% | 79.0% | 75.7% | 0.34 |
Ampicillin /Sulbactam | 16 | 74.0% | 74.9% | 71.0% | 0.24 |
Cefaclor | 16 | 48.3% | 48.9% | 46.3% | 0.45 |
Cefazolin | 16 | 55.7% | 56.6% | 52.7% | 0.29 |
Cefepime | 16 | 50.3% | 51.8% | 45.4% | 0.07 |
Cefoxitin | 16 | 46.9% | 47.1% | 46.3% | 0.82 |
Ceftazidime | 16 | 45.4% | 46.0% | 43.1% | 0.40 |
Ceftriaxone | 16 | 44.7% | 43.4% | 49.0% | 0.12 |
Ciprofloxacin | 2 | 64.4% | 65.3% | 61.3% | 0.23 |
Levofloxacin | 2 | 70.1% | 71.3% | 66.2% | 0.11 |
Meropenem | 6 | 75.9% | 78.1% | 68.8% | 0.002 |
Piperacillin /Tazobactam | 16 | 64.3% | 67.4% | 54.3% | <0.0001 |
Vancomycin | 3 | 56.2% | 58.5% | 39.5% | 0.02 |
Note: Statistically significant p values (p < 0.05) were shown in bold fonts.